MSB 1.04% $1.46 mesoblast limited

banter and General Discussion, page-6906

  1. 7,872 Posts.
    lightbulb Created with Sketch. 1354
    Considering the evidence from the trial showed no benefit in adults, I'd suspect we would need a different trial, no?

    Or are we just forgoing evidence based medicine in favour of the shareholders these days?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.